1. Home
  2. ELAB vs CELZ Comparison

ELAB vs CELZ Comparison

Compare ELAB & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELAB
  • CELZ
  • Stock Information
  • Founded
  • ELAB 2020
  • CELZ 1998
  • Country
  • ELAB United States
  • CELZ United States
  • Employees
  • ELAB N/A
  • CELZ N/A
  • Industry
  • ELAB
  • CELZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELAB
  • CELZ Health Care
  • Exchange
  • ELAB Nasdaq
  • CELZ Nasdaq
  • Market Cap
  • ELAB 6.6M
  • CELZ 5.5M
  • IPO Year
  • ELAB 2023
  • CELZ N/A
  • Fundamental
  • Price
  • ELAB $2.47
  • CELZ $2.02
  • Analyst Decision
  • ELAB
  • CELZ
  • Analyst Count
  • ELAB 0
  • CELZ 0
  • Target Price
  • ELAB N/A
  • CELZ N/A
  • AVG Volume (30 Days)
  • ELAB 711.3K
  • CELZ 34.9K
  • Earning Date
  • ELAB 05-23-2025
  • CELZ 05-09-2025
  • Dividend Yield
  • ELAB N/A
  • CELZ N/A
  • EPS Growth
  • ELAB N/A
  • CELZ N/A
  • EPS
  • ELAB N/A
  • CELZ N/A
  • Revenue
  • ELAB N/A
  • CELZ $14,000.00
  • Revenue This Year
  • ELAB N/A
  • CELZ N/A
  • Revenue Next Year
  • ELAB N/A
  • CELZ N/A
  • P/E Ratio
  • ELAB N/A
  • CELZ N/A
  • Revenue Growth
  • ELAB N/A
  • CELZ 55.56
  • 52 Week Low
  • ELAB $2.14
  • CELZ $1.69
  • 52 Week High
  • ELAB $980.00
  • CELZ $6.90
  • Technical
  • Relative Strength Index (RSI)
  • ELAB 37.57
  • CELZ 44.81
  • Support Level
  • ELAB $2.37
  • CELZ $1.94
  • Resistance Level
  • ELAB $2.55
  • CELZ $2.20
  • Average True Range (ATR)
  • ELAB 0.22
  • CELZ 0.14
  • MACD
  • ELAB 0.15
  • CELZ 0.04
  • Stochastic Oscillator
  • ELAB 31.13
  • CELZ 40.00

About ELAB Elevai Labs Inc.

PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Share on Social Networks: